Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
Journal of Cancer Research and Therapeutics, a publication of Association of Radiation Oncologists of India (AROI), is a peer-reviewed online journal with Quarterly print on demand compilation of issues published. The journalís full text is available online at http://www.cancerjournal.net. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs.
CURRENT COVER
EDITORIAL BOARD

Editor in Chief
Dr. Nagraj Huilgol

Executive Editor
Rajiv Sarin, Mumbai, India

Associate Editor
Rakesh Jalali, Mumbai, India

View All Members

JCRT STATISTICS
  • 2,555 Total articles
  • 2,552 Full text articles
  • 74 Manuscripts submitted in '17
  • 81,634 Articles downloaded in 'December 2016

Special Issue

September 2013 Volume 9 | Issue 5 (Supplement)

Special Issue

November 2013 Volume 9 | Issue 7 (Supplement)

CURRENT ISSUE
July-September 2016| Vol 12| Issue 3

Editorial

Big data in radiation oncology

Radiation oncology (RO) is data rich as much as technology intensive. Decision-making in RO is algorithmic and is based on the evidence gathered over various platforms. A lot of data generated are in ...


Review Article

Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer

Papillary and follicular cancers of thyroid are the most common varieties of differentiated thyroid cancers exhibiting excellent long-term prognosis when carefully managed. Being a slow-growing malign...


Review Article

Management of the neck in early oral cancers: Is the verdict out?

The management of patients with the clinically negative neck (N0) in early oral cancers awaits a clear mandate despite growing evidence favoring elective neck dissection. Having a general policy of op...


Original Article

Samarium-153-(4-[((bis (phosphonomethyl)) carbamoyl) methyl]-7,10-bis (carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl) acetic acid: A novel agent for bone pain palliation therapy

Aim: Various phosphonate ligands labeled with β-emitting radionuclides have shown good efficacy for bone pain palliation. In this study, a new agent for bone pain palliat...


View All Articles